Four-way crossover study of extended-release oral formulations of EV-077.
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2010
At a glance
- Drugs SER 150 (Primary)
- Indications Cardiovascular disorders; Thrombosis
- Focus Pharmacokinetics
- 21 Dec 2010 New trial record
- 16 Dec 2010 This trial has been completed, according to an Evolva media release.